Recurrent erysipelas: 47 Cases

Dermatology

Volumn 214, Issue 1, 2006, Pages 52-57

  Leclerc, S ^a,b   Teixeira, A ^a   Mahe E ^b   Descamps, V ^b   Crickx, B ^b   Chosidow, O ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL TENON   (France)

Author keywords

Antibiotic prophylaxis; Cellulitis; Erysipelas

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; PENICILLIN G; PRISTINAMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; ERYSIPELAS; FEMALE; GENERAL CONDITION; HOSPITAL ADMISSION; HUMAN; INTERTRIGO; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ERYSIPELAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33845959671     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096913     Document Type: Article

References (25)

1. Bernard P, Chosidow O, Vaillant L on behalf of the French Erysipelas Study Group: Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomized, non-inferiority, open trial. BMJ 2002;325:864.
2. Crickx B, Chevron F, Sigal-Nahum M, et al: Erysipèle: données épidémiologiques, cliniques et thé rapeutiques. Ann Dermatol Vénéréol 1991;118:11-16.
3. Eriksson B, Jorup-Ronstrom C, Karkkonen K, et al: Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-1098.
4. Jorup-Ronstrom C, Britton S: Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection 1987;15:105-106.
5. Mahé E, Toussaint P, Lamarque D, et al: Erysipèles dans la population jeune d'un hôpital militaire. Ann Dermatol Véné réol 1999;126:593-599.
6. Dupuy A, Benchiki H, Roujeau JC, et al: Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999;318:1591-1594.
7. Breiman L, Freiman JH, Olshen RA, Stone CJ: Regression trees; in Kimmel J (ed): Classification and Regression Tree, ed 3. Belmont, Wadsworth, 1998, pp 216-265.
8. Clark LA, Pregibon DA: Tree-based models; in Chambers JM, Haskie TJ (eds): Statistical Models in S. New York, Wadsworth, 1991, pp 377-420.
9. Semel JD, Goldin H: Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis 1996;23:1162-1164.
10. Roujeau JC, Sigurgeirsson B, Korting HC, et al: Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study. Dermatology 2004;209:301-307.
11. Mokni M, Dupuy A, Denguezli M, et al: Risk factors for leg cellulitis in Tunisia: a multicenter case-control study. Dermatology 2006;212:108-112.
12. Swartz MN: Clinical practice. Cellulitis. N Engl J Med 2004;350:904-912.
13. Baddour LM, Bisno AL: Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA 1984;251:1049-1052.
14. Del Giudice P, Chosidow O: Superficial pyodermas: advances, recommendations and needs. Dermatology 2005;210:367-369.
15. Ray WA, Murray KT, Meredith S, et al: Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089-1096.
16. Lanoux P, Penalba C, Legin C, et al: L'érysipèle. A propos de 118 observations. Méd Mal Infect 1993;23:908-912.
17. Allard P, Stucker M, von Kobyletzki G, et al: Zyklische intravenöse Antibiose als effizientes Therapiekonzept des chronisch-rezidivierenden Erysipels. Hautarzt 1999;50:34-38.
18. Kremer M, Zuckerman R, Avraham Z, et al: Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 1991;22:37-40.
19. Wang JH, Liu YC, Cheng DL, et al: Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis 1997;25:685-689.
20. Chakroun M, Ben Romdhane F, Battikh R, et al: Intérêt de la benzathine pénicilline dans la prévention des récidives d'érysipèle. Méd Mal Infect 1994;24:894-897.
21. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, et al: Antibiotic prophylaxis in recurrent erysipelas. Infection 1993;21:390-393.
22. Jorup-Ronstrom C: Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-524.
23. Meunier F, Pascot M, Boursier V, et al: Traite ment prophylactique des érysipèles récidivants au cours des lymphoedèmes secondaires du membre supérieur. Ann Dermatol Vénéré ol 2003;130:694-695.
24. Chartier C, Grosshans E: Erysipelas. Int J Dermatol 1990;29:459-467.
25. Ronnen M, Suster S, Schewach-Millet M, Modan M: Erysipelas. Changing faces. Int J Dermatol 1985;24:169-172.